Architect Financial Technologies said it raised $35 million, its largest fundraising round since its founding nearly three ...

Chicago-headquartered Architect Financial Technologies has raised $35 million in strategic Series A funding, marking a ...

Following formal grant, the patent is expected to remain in force until at least 2040, excluding any available patent term extensions. With this decision, Oryzon has now secured patent protection for ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

Michael Boyle is an experienced financial professional with more than 10 years working with financial planning, derivatives, equities, fixed income, project management, and analytics. Amanda Jackson ...

NUGT's 2x leverage amplifies both upside and risk, with a 77% historical standard deviation and a technical setup targeting ...

The UK furniture and floorcoverings market sees growth potential post-2024 decline, driven by rising discretionary incomes of affluent consumers seeking high-quality, big-ticket items. DFS and Tapi ...

Bristol-Myers Squibb raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus. Click here to find out why BMY is a Buy.

The market operates within a dynamic landscape shaped by industrial diversification, growing preference for plant-based ...

Natural products are small molecules produced naturally by any organism including primary and secondary metabolites. They include very small molecules, such as urea, and complex structures, such as ...

Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...